Ads
related to: thalassemia beta minor treatment- Prescribing Information
View Full Prescribing Information &
Indications And Usage.
- Find Treatment Centers
Find an Authorized Treatment Center
By Using the Map Search Feature.
- Treatment Journey
Learn More About Treatment And
See If It's Right for Your Patients
- Safety and Side Effects
Review the Safety Profile
And Potential Side Effects.
- HCP Resources
Download Treatment Brochures,
Billing Codes, and More.
- Important Safety Info
View Warnings And Precautions.
Understand the Potential Risks.
- Prescribing Information
Search results
Results From The WOW.Com Content Network
Patients with beta thalassemia minor are usually asymptomatic and are often monitored without treatment. [8] Beta thalassemia minor may coexist with other conditions such as chronic hepatitis B, chronic hepatitis C, non-alcoholic fatty liver disease and alcoholic liver disease that, when combined or co-existing, may cause a person to have iron ...
Betibeglogene autotemcel, sold under the brand name Zynteglo, is a gene therapy for the treatment for beta thalassemia. [33] It was approved for medical use in the European Union in May 2019, [34] and in the United States in August 2022.
β thalassemia minor is caused by a β/ ... Betibeglogene autotemcel, sold under the brand name Zynteglo, is a gene therapy for the treatment for beta thalassemia. [58]
Betibeglogene autotemcel, sold under the brand name Zynteglo, is a gene therapy for the treatment for beta thalassemia. [1] [5] [2] It was developed by Bluebird Bio and was given breakthrough therapy designation by the US Food and Drug Administration in February 2015.
For premium support please call: 800-290-4726 more ways to reach us
Exagamglogene autotemcel, sold under the brand name Casgevy, is a gene therapy used for the treatment of sickle cell disease [3] [5] and transfusion-dependent beta thalassemia. [3] It was developed by Vertex Pharmaceuticals and CRISPR Therapeutics. [9]
Ads
related to: thalassemia beta minor treatment